Caryn Peterson insider trades
Open-market stock purchases and sales by Caryn Peterson, Chief Development Officer at Gossamer Bio, Inc, from SEC Form 4 filings since Apr 16, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 24, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $105K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $340K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $172K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $28.8K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $25.6K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $31K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $12.5K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $44K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $228K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $198K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $169K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $56.3K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $70.9K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $57K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $9.5K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $8.5K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $10.3K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $4.1K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $14.6K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $1.5M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $497K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $364K |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
Companies traded
- GOSS Gossamer Bio, Inc: 5 sales, last Aug 24, 2026